Table 1.

Baseline Characteristics of Study Participants From the SCUT Trial, Stratified on Eligibility for and Inclusion in the Current Study

Baseline Characteristic	Eligible SCUT Participants		Ineligible SCUT Participants,N= 420	PValue*
	Included,N= 50	Excluded,N= 30
Female sex, N (%)	25 (50%)	10 (33.3%)	192 (45.7%)	0.33
Age, y, median (IQR)	45 (38–60)	56 (37–65)	53 (40–62)	0.14
LogMAR visual acuity, median (IQR)	0.65 (0.36–1.6)	1.36 (0.64–1.7)	0.81 (0.36–1.7)	0.16†
Infiltrate size, mm2, median (IQR)	2.5 (1.9–3.7)	3.2 (1.9–5.1)	2.7 (1.9–4.0)	0.32
Steroid group, N (%)	24 (48.0%)	15 (50.0%)	211 (50.2%)	0.98
Causative organism, N (%)
S. pneumoniae	21 (42.0%)	15 (51.7%)	214 (51.0%)	0.50
Nocardia species	14 (28.0%)	4 (13.3%)	38 (9.1%)	0.001‡
P. aeruginosa	12 (24.0%)	7 (23.3%)	92 (21.9%)	0.88
Other	3 (6.0%)	4 (13.3%)	77 (18.3%)	0.07§

^*Kruskal-Wallis test or Fisher's exact test.

^†Pairwise comparisons: eligible included versus eligible excluded, P = 0.06; eligible included versus ineligible, P = 0.81.

^‡Pairwise comparisons: eligible included versus eligible excluded, P = 0.17; eligible included versus ineligible, P < 0.001.

^§Pairwise comparisons: eligible included versus eligible excluded, P = 0.23; eligible included versus ineligible, P < 0.02.